|
|
||||||||
Department of Molecular, Cellular, and Animal Biology, University of Camerino, I-62032 Camerino, Italy
| |
ABSTRACT |
|---|
|
|
|---|
The aim of
the present research was to study the role of angiotensin-converting
enzyme (ACE) and ANG II in amphibian (Rana esculenta) testicular steroidogenesis and
prostaglandin production. Hormonal effects of ACE, ACE inhibitors,
synthetic bullfrog ANG I, and
[Val5]ANG II were
determined in frog testis of prereproductive period. Production of
17
-estradiol, progesterone, androgens, and
PGE2 and
PGF2
was determined by
incubating frog testes with ACE (2.5 mU/ml), captopril (0.1 mM),
lisinopril (0.1 mM),
[Val5]ANG II (1 µM), and synthetic bullfrog ANG I (1 µM). The analysis of the data showed
an independent modulation of
17
-estradiol and androgen production
by ACE and ANG II. The ACE pathway caused a decrease of
17
-estradiol production and an
increase of androgen production in frog testes; on the other hand, the
ANG II pathway increased
17
-estradiol production and
decreased androgen production. The determination of testicular
aromatase activity showed a positive regulation by ANG II and a
negative regulation by ACE. As for prostaglandin production, only ANG
II influenced PGF2
. These results suggest a new physiological role of ACE and ANG II in modulating steroidogenesis and prostaglandin production.
17
-estradiol; progesterone; androgens; prostaglandin
E2; prostaglandin
F2
; angiotensin-converting enzyme
| |
INTRODUCTION |
|---|
|
|
|---|
ANGIOTENSIN-CONVERTING ENZYME (ACE; EC 3.4.15.1) is a glycosylated integral membrane protein located on the luminal surface of the cell membrane. Known primarily for its role in the regulation of blood pressure and hydromineral metabolism, it is found in a large variety of cells, tissues, and biological fluids including plasma, semen, proximal renal tubular cells, intestinal epithelial cells, stimulated macrophages, brain, lung, vascular endothelium, and the medial and adventitial layers of blood vessel walls (16). ACE is a peptidyl dipeptidase that removes the carboxy terminal His-Leu from ANG I to produce the octapeptide ANG II, and, in addition, inactivates bradykinin, a mediator of inflammation and vasodilator peptide, as well as substance P, enkephalins, and endorphins (17). There are two isozyme forms: a larger one of 150-180 kDa protein encoded by a 4.4-kb mRNA found in somatic cells and a smaller one of 100-110 kDa protein encoded by a 3-kb mRNA found in testicular germ cells. These two ACE isozymes are encoded by the same gene, which is transcribed in two different mRNAs (19). Cloning and sequencing of the human germinal ACE cDNA (8) have revealed that it corresponds to the COOH terminal of the somatic ACE cDNA. The transcription of germinal ACE occurs via a testis-specific promoter located within intron 12 of the ACE gene (17, 18, 22, 33). In addition, the germinal isoform possesses a specific NH2-terminal sequence transcribed from exon 13, which is absent in the somatic ACE cDNA due to an alternative splicing (17, 22, 33). In the mouse, the two ACE cDNAs (somatic and germinal) (1, 2, 23) revealed the same structure as the human cDNAs and a high degree of homology both in amino acid and nucleotide sequences. The germinal isozyme of ACE was shown to be tissue and stage specific during spermatogenesis in mouse and rat testes: it is exclusively expressed in male germ cells after completion of meiosis and throughout spermiogenesis (31). In rat, a positive regulation of testicular ACE expression by androgens and luteinizing hormone was reported (36), but in the prepubertal period the germinal isozyme of ACE has not been detected. The function of testicular ACE is unknown, although studies with ACE-deficient mice demonstrated reduced male fertility in homozygous mutants (9, 13, 21).
Components of the prorenin-renin-ANG system (PRAS) are present locally within the male reproductive tissue (27). PRAS may be considered an important member of the local regulatory system, producing ANG II needed for paracrine functions. ANG II receptors have been demonstrated to be present in the testis of rat and several primate species including humans (25). In all species examined, Leydig cells possessed specific ANG binding sites. ANG II inhibited adenylate cyclase activity in Leydig cell membranes and reduced basal and human chorionic gonadotropin-stimulated cAMP pools and testosterone production in intact cells (20). In Sertoli cells, ANG II increased cytosolic calcium through AT2-receptor subtypes in a cAMP-independent pathway (12).
In a previous report, we studied the role of ACE and ANG II in ovarian
steroidogenesis and prostaglandin production in the water frog,
Rana esculenta (4).
17
-Estradiol, progesterone, and
PGE2 production was modulated by
ovary ACE; on the other hand, [Val5]ANG II modulated
the production of progesterone and
PGF2
, whereas androgen
production was not influenced. These studies suggested the existence of
two pathways, independently regulated by ACE and ANG II, modulating
ovarian steroidogenesis and prostaglandin production.
The present study was undertaken in an attempt to determine the role of
ACE and ANG II on testicular steroidogenesis and prostaglandin production in amphibians and to confirm the presence also in frog testis of two pathways regulated by ACE- and ANG II-modulating steroidogenesis and prostaglandin production. Furthermore, the results
suggest the paracrine action of ANG II and the physiological function
of testis ACE. We followed the production of
17
-estradiol, progesterone,
androgens, and PGE2 and
PGF2
in in vitro incubation of
testicular tissue of Rana esculenta in
the prereproductive period, and the data obtained showed a modulation
of 17
-estradiol and androgen
production by ACE and ANG II acting on aromatase activity. ANG II also
modulated the production of
PGF2
. Progesterone and
PGE2 production was not
influenced. The results confirm the presence of two pathways modulating
steroidogenesis and prostaglandin production as reported in the frog ovary.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Chemicals
N-[3-(2-furyl)acryloyl]-L-phenylalanyl-glycyl-glycine (FAPGG), N-[3-(2-furyl)acryloyl]-L-phenylalanine (FAP), [Val5]ANG II (Asp-Arg-Val-Tyr-Val-His-Pro-Phe), bullfrog ANG I (Asp- Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu), ACE (rabbit lung), captopril, lisinopril, DMEM, penicillin G, streptomycin, progesterone, testosterone, 17
-estradiol,
PGF2
,
PGE2, and acetylsalicylic acid
were purchased from Sigma (St. Louis, MO).
Acetonitrile and aqualyte were from J. T. Baker (Deventer,
Netherlands), trifluoroacetic acid (TFA) was from Fluka (Buchs,
Switzerland). Trypsin (bovine pancreas) was from Boehringer Mannheim
(Germany), and trypsin inhibitor (bovine lung) was from Serva
Feinbiochemica (Heidelberg/New York). HPLC column was Supelcosil LC-318
from Supelco (Bellefonte, PA). Multiwell tissue culture plates were
from Becton Dickinson (Lincoln Park, NJ). Progesterone, androgens,
17
-estradiol, and PGF2
antisera were provided by
Dr. G. F. Bolelli (CNR-Institute of Normal and Pathologic
Cytomorphology, University of Bologna, Italy) and Dr. F. Franceschetti (CNR-Physiopathology of Reproduction Service,
University of Bologna, Italy), and the
PGE2 antiserum was purchased from
Cayman Chemical (Ann Arbor, MI).
[1,2,6,7-3H]progesterone,
[1,2,6,7-3H]testosterone,
[2,4,6,7-3H]17
-estradiol,
[5,6,8,9,11,12,14,15(n)-3H]PGF2
,
and [5,6,8,11,12,
14,15(n)-3H]PGE2
were purchased from Amersham (Buckinghamshire, UK).
Animals
Adult male Rana esculenta frogs (average weight, 23 g) were collected in Umbria, Italy, from Colfiorito pond (870 m above sea level). This frog population breeds in May (reproductive period; when the temperature increases) and enters a postreproductive period in the summer. Gonad recrudescence is initiated in midsummer and continues into autumn (recovery period). The animals hibernate during the cold months of winter in ground shelters (hibernation period) to emerge when the temperature increases in the following spring. At the beginning of spring, the frogs return to the pond (prereproductive period).Preparation of Crude Homogenates, Tissue Membranes, and Testicular Trypsin Extraction
The preparation of crude homogenates, tissue membranes, and testicular trypsin extraction followed a method previously described (4). Protein content was evaluated by the method of Bradford (3), with bovine serum albumin as standard. Six adult male frogs were used for each extraction.Experimental Protocol
In vitro studies. To study the testicular steroidogenesis and prostaglandin production, male frogs from the prereproductive period were captured and killed in the field by decapitation. The testes were removed, placed in cold DMEM containing 10 mM Hepes, 0.1 mg/ml penicillin G, and 0.1 mg/ml streptomycin, and transferred to the laboratory where they were distributed over incubation wells (2 testes/well) each containing 2 ml of incubation medium (10). Each incubation set of wells was divided into six experimental groups (each consisting of 4 wells): 1) medium alone; 2) medium plus 2.5 mU/ml rabbit lung ACE; 3) medium plus 0.1 mM captopril; 4) medium plus 0.1 mM lisinopril; 5) medium plus 0.1 mM captopril plus 2.5 mU/ml rabbit lung ACE; and 6) medium plus 0.1 mM lisinopril plus 2.5 mU/ml rabbit lung ACE. [Val5]ANG II and synthetic bullfrog ANG I, at the final concentration of 1 µM, were added to a second and third incubation set, respectively. In a fourth incubation set, 2.5 mU/ml rabbit lung ACE were replaced with 2.5 mU/ml trypsinized frog testis ACE. Acetylsalicylic acid, at the final concentration of 2.5 µM, was added to a fifth and sixth incubation set containing 1 µM [Val5]ANG II and 1 µM synthetic bullfrog ANG I, respectively. In a seventh incubation set, PGF2
was added at the final
concentration of 100 nM. Culture plates were wrapped in aluminium foil
and incubated at room temperature. The incubation medium was removed
after 6 h and stored at
20°C until hormone assays. The
control experiment was repeated with incubation media without
testicular tissue.
Aromatase activity determination.
Testes were weighed and homogenized in cold buffer (50 µl/mg fresh weight tissue; 20 mM K2HPO4,
1 mM EDTA, 3 mM NaN3, 10%
glycerol, and 10 mM
-mercaptoethanol, pH 7.4). The
determination of aromatase activity was performed as reported by Zerani
et al. (38).
Determination of FAPGG Hydrolyzing Activity and Kinetic Parameters
The determination of FAPGG hydrolytic activity and kinetic parameters of testis ACE followed a method previously described for ovary ACE (4).Hydrolysis of ANG I by Homogenate and Membrane Suspension of Testis
Homogenate (5 µg) or membrane suspension (1 µg) of testis was added to 100 µM synthetic bullfrog ANG I solution in 80 mM borate buffer (pH 8.2) containing 300 mM NaCl in a total volume of 20 µl. The solution was incubated at 37°C for 5 min. TFA was used to acidify to pH 2.0, stopping the incubation, and the solution was injected for reverse-phase HPLC analysis using a 5-µm Supelcosil LC-318 column protected with a 5-µm Supelcosil LC-318 guard column (2 cm × 4.6 mm ID). The elution was performed with a linear gradient from 15 to 35% of 0.1% TFA in water and 0.1% TFA in acetonitrile at a flow rate of 1 ml/min. Eluate absorbance was monitored by ultraviolet absorbance at 214 nm. Identification of the ANG II peak was facilitated by adding 1 nmol of [Val5]ANG II to the mixture after incubation and before injection of the sample for reverse-phase HPLC analysis or by incubating the mixture with 0.1 mM captopril.Determination of Progesterone, Androgens,
17
-Estradiol,
PGF2
, and
PGE2
-estradiol,
PGF2
, and
PGE2 were measured in incubation
media by RIA as described previously (10). Intra- and interassay
coefficientsof variation and minimum detectable doses were:
progesterone, 9%, 16%, 12 pg; androgens, 12%, 18%, 19 pg;
17
-estradiol, 8%, 19%, 11 pg;
PGF2
, 9%, 18%, 15 pg; and
PGE2, 7%, 17%, 17 pg.
Testosterone was not separated from
5
-dihydrotestosterone and,
therefore, as the antiserum used is not specific, the data are
expressed as androgens.
Statistical Analysis
ANOVA followed by Duncan's multiple range test (7, 32) was used to analyze the data.| |
RESULTS |
|---|
|
|
|---|
The ACE activity contents of lung, kidney, and testis of frog
(R. esculenta) were measured by
following the hydrolyzing activity of crude tissue homogenates on
FAPGG, a synthetic substrate of ACE. As reported in Table
1, the FAPGG hydrolyzing activity is present in lung and kidney of male frog with values very close to those
reported for the female frog (4). The hydrolyzing activity in testis
was ~70-90 times less than the activities in the kidney and lung
tissue and ~1,100 times less compared with the FAPGG hydrolyzing
activity of ovary tissue (in reference to the weight).
|
To compare the kinetic parameters of ovary ACE with testis ACE, a
partial purification of the enzyme from testicular tissue was carried
out after the partial purification procedure of ovary ACE. Linear
regression analysis of FAPGG hydrolysis by tissue membrane preparation
gave a Michaelis-Menten constant (Km) of 0.297 ± 0.044 mM and a maximum velocity of 5.164 ± 0.352 nmol · min
1 · mg
protein
1. Captopril and
lisinopril, two specific ACE inhibitors, inhibited the enzyme activity
at low concentration. The IC50
values, obtained from inhibition curves, were 26.600 ± 0.322 nM for
captopril, and 1.326 ± 0.575 nM for lisinopril using FAPGG as substrate.
Frog testicular membrane suspension was incubated at 37°C in the
presence of synthetic bullfrog ANG I. Aliquots of incubation mixture
were drawn at different times and analyzed by reverse-phase HPLC. The
chromatographic elution profiles showed the presence of a peak that
corresponds to
[Val5]ANG II by
comparison with a standard sample of synthetic
[Val5]ANG II.
Captopril and lisinopril at the concentration of
10
4 M inhibited the
production of
[Val5]ANG II almost
completely. Comparison of these data from testis ACE with those
obtained from ovary ACE shows a high degree of homology in kinetic parameters.
To study the physiological function of ACE on steroidogenesis and
prostaglandin synthesis in frog testis, the production of 17
-estradiol, progesterone,
androgens, PGE2, and
PGF2
was determined by
incubating in vitro testicular tissue in the presence of captopril,
lisinopril, rabbit lung ACE,
[Val5]ANG II,
synthetic bullfrog ANG I, and frog testicular ACE.
The data show that the basal production of progesterone (127 ± 45 pg/testis) in frog testis remained unchanged after treatment of frog
testicular tissue with captopril, lisinopril, rabbit lung ACE,
[Val5]ANG II,
synthetic bullfrog ANG I, and frog testis ACE. Figure 1 shows the
17
-estradiol production by frog
testis incubated in vitro. The
17
-estradiol basal value of 151.3 ± 26.11 pg/testis was inhibited by adding rabbit lung ACE at the
final concentration of 2.5 mU/ml (Fig.
1A). Treatment with specific ACE
inhibitors captopril (0.1 mM) and lisinopril (0.1 mM) increased the
production of 17
-estradiol
approximately fourfold over the basal level (Fig. 1A). Addition of 1 µM
[Val5]ANG II to the
incubation medium caused an increase of
17
-estradiol (450%) that was
nullified by addition of rabbit lung ACE (Fig. 1B). The presence of ACE inhibitors
with ANG II amplified 17
-estradiol production by about nine times for captopril and about 10 times for
lisinopril, even with the addition of rabbit lung ACE. In Fig.
1C, addition of 1 µM ANG I to the incubation medium
stimulated 17
-estradiol as reported
for addition of ANG II. The presence of rabbit lung ACE nullified the
stimulus of ANG I. ACE inhibitors prevented conversion of ANG I to ANG
II, obtaining an increase of
17
-estradiol production due only to
the presence of inhibitors. To avoid contamination in the commercial
rabbit lung ACE influencing the results, frog testis ACE was partially
purified as described in MATERIALS AND METHODS. The amount
of frog testis ACE used in the test was 2.5 mU/ml. The data confirm the
results obtained with rabbit lung ACE (Fig.
1D) and suggest the presence in the frog testis of two pathways controlling
17
-estradiol production. The first
involves an ACE pathway and the second an ANG II pathway independent of
ACE conversion.
|
Figure 2 shows androgen production (basal
value 2,601 ± 254.1 pg/testis) by frog testis incubated in vitro.
Unlike in the case of 17
-estradiol
production, the addition of rabbit lung ACE (2.5 mU/ml) to the
incubation medium increased the androgen production approximately
twofold compared with the basal value. Treatment with ACE inhibitors
caused a decrease of androgen production (~65%) also in presence of
rabbit lung ACE (Fig. 2A). Addition of ANG II to the incubation medium also led to a decrease in androgen production (~58%), which was nullified by rabbit lung ACE but enhanced by ACE inhibitors. These data confirm the results obtained with 17
-estradiol, in which two
pathways modulating hormone production in frog testis are present.
Addition of 1 µM synthetic bullfrog ANG I to the incubation medium confirmed the data obtained with ANG II
(Fig. 2C). ANG I inhibited androgen
production via ANG II conversion by endogenous ACE, whereas the
presence of rabbit lung ACE nullified the stimulus of ANG I. ACE
inhibitors prevented conversion of ANG I to ANG II and obtained a
decrease of androgen production due only to the presence of ACE
inhibitors. The addition of partially purified frog testis ACE
confirmed the data obtained with rabbit lung ACE.
|
The analysis of results regarding the influence of ACE and ANG II on
17
-estradiol and androgen production
revealed an opposite effect. Addition of ACE to testicular tissue
caused a decrease of 17
-estradiol
and an increase of androgen production, whereas ANG II showed an
increase of 17
-estradiol and a
decrease of androgen production. These data suggest an influence of the
ACE and ANG II pathways in modulating aromatase activity, the enzyme
complex that catalyzed the conversion of androgens to estrogens. With this in view, aromatase activity was determined in homogenates of frog
testis after treatment with rabbit lung ACE, captopril, lisinopril,
[Val5]ANG II,
synthetic bullfrog ANG I, and frog testis ACE. Figure 3 shows the aromatase activity of frog
testis homogenates after incubation in vitro. The data show the same
pattern seen in 17
-estradiol production, confirming the influence of ACE and ANG II on aromatase activity in frog testicular tissues.
|
We found a difference in modulation of prostaglandin production by ACE
and ANG II in frog ovary (4). The ACE pathway acted on
PGE2, whereas that of ANG II
regulated PGF2
. To confirm these data, PGE2 and
PGF2
production were determined
in frog testis after treatment with rabbit lung ACE, captopril,
lisinopril, [Val5]ANG
II, synthetic bullfrog ANG I, and frog testis ACE. Figure 4 shows
PGF2
production (expressed as
pg/testis) by frog testicular tissue incubated in vitro. The data show
the same pattern as seen in
PGF2
production in frog ovary.
The basal value of PGF2
(275 ± 41.5 pg/testis) remained unchanged in the presence
of rabbit lung ACE, captopril, and lisinopril (Fig.
4A). ANG II (1 µM) increased the production of
PGF2
(331%) without any
influence of rabbit lung ACE and/or ACE inhibitors (Fig.
4B). The production of
PGE2 (basal value 485 ± 37 pg/testis) was not affected by rabbit lung ACE, captopril, lisinopril,
[Val5]ANG II,
synthetic bullfrog ANG I, or frog testis ACE.
|
In the present paper, we show that ANG II is able to increase
PGF2
production and to enhance
aromatase activity in frog testis. Gobbetti and Zerani (11) reported
that aromatase activity is influenced by
PGF2
in the brain of the newt
Triturus carnifex during male
courtship. Therefore, frog testis was incubated in vitro with ANG II
and with ANG I in presence of an inhibitor of prostaglandin synthesis
(2.5 µM acetylsalicylic acid) and
with PGF2
(100 nM). The results
exclude the involvement of PGF2
in modulating aromatase activity.
| |
DISCUSSION |
|---|
|
|
|---|
The aim of the present study was to examine the role of ACE and ANG II in testicular steroidogenesis and prostaglandin production in Rana esculenta. Male frogs appear to be potentially continuous breeders, producing spermatozoa throughout the entire year, with cysts of all spermatogenetic stages being always present (24). Temperature is the primary factor in the regulation of the testicular cycle quiescent phase during winter. Rana esculenta (southern European populations) shows a new wave of spermatogenesis in spring immediately before the spring-summer breeding commences (28). Therefore, we studied the hormonal effects of ACE, ACE inhibitors, ANG I, and ANG II in the prereproductive period.
The ACE activity present in homogenate of frog testis is very low compared with other tissues of frog, but the data are in agreement with what was reported for Rana catesbeiana (37). The low value of ACE activity found for frog testis is also in agreement with what was reported for humans, in which the testis ACE activity is approximately threefold less than lung ACE activity (34). However, the data are in contradiction with the findings for rat and mouse testis (6, 14), in which ACE activity is higher in the testis than in the lung. These differences may be explained by the different procedures used for sample preparation; in fact, rat and mouse testis homogenates were repeatedly dialyzed.
With regard to the kinetic parameters, the frog testis ACE shows a Km value very close to that of frog ovary for the synthetic substrate FAPGG, whereas IC50 values of captopril and lisinopril are slightly lower than those of frog ovary ACE (4).
In a previous report, we gave evidence for two pathways independently
regulated by ACE and ANG II and modulating the steroidogenesis and
prostaglandin production in amphibian ovary. More precisely, ovary ACE
was involved in modulating 17
-estradiol, progesterone, and
PGE2, whereas ANG II modulated the
production of progesterone and
PGF2
(4). Data obtained in in
vitro incubation of testis tissue with ACE and ACE inhibitors suggest
the involvement of ACE activity reducing
17
-estradiol production; instead,
ANG II, exogenous or derived from ANG I hydrolysis, showed positive results on 17
-estradiol production.
The experiments performed to study the effect of ACE, ANG I, and ANG II
on androgen secretion showed opposite results compared with data
obtained for 17
-estradiol. Indeed,
the increase of androgen production was due to the ACE activity,
whereas ANG II caused negative modulation. The observation that ANG II
produced an inhibitory effect on androgen production was in agreement
with data reported in mammals by Khanum and Dufau (20), where ANG II
inhibited adenylate cyclase activity in rat Leydig cell membranes and
reduced basal and human chorionic gonadotropin- stimulated cAMP pools
and testosterone production in intact cells. The experiments performed
to study the effects of ACE, ANG I, and ANG II on
17
-estradiol and androgen production
suggest the presence, also in the frog testis, of two pathways
independently regulated by ACE and ANG II, as seen in frog ovary.
In frog testis, the pathways regulated by ACE activity and ANG II seem
to involve the modulation of aromatase activity. In Fig. 5, we propose
a schema, derived from analysis of our experimental data, in which ACE
and ANG II have an opposite effect in modulating aromatase activity in
frog testis. This model explains some paracrine functions activated by
ACE via 17
-estradiol modulation of
reproductive processes. Rana esculenta
displayed high estrogen peaks in plasma and testes concomitantly with a
sharp androgen decrease in postreproductive period (35). According to
our model, decrease of testicular ACE in frog testis, due to discharge
of spermatozoa during the breeding period, may increase aromatase
activity with a consequent rise in
17
-estradiol level and decrease in
androgen level. The 17
-estradiol
peak in postreproductive period may induce cellular proliferative
activity in primary spermatogonial cells, as reported by Minucci et
al. (26).
|
In mammals, testicular ACE was expressed exclusively in the haploid
germ cell of mouse and rat testis. In both species, the highest level
of expression was associated with the elongation of spermatids at
steps 10-11, although in
prepubertal animals, hardly any signals were seen. The first signal
appeared from day 23 of age; its
intensity gradually increased until, at days 28-35, an
adult level of ACE mRNA expression was reached. A close correlation between the germ cell- specific formation of testicular ACE and maturation of the germ cell exists (31). Recently, in adult male bonnet
monkeys (Monkey
radiata) treated with a long-acting nonsteridal aromatase inhibitor (CGP 47645), a marked reduction in
sperm counts with inhibition in spermiogenic processes was observed
(30). In humans, mutation dysfunction in estradiol receptor
and aromatase decreased sperm
counts and resulted in poor sperm viability (5). These data, explained
with our model, suggest the involvement of testicular ACE activity in a
feedback control of spermatogenetic progression regulating the
production of estrogen via aromatase activity modulation in the testis.
Recently, Hess et al. (15) have reported that estrogen also regulates
the reabsorption of luminal fluid in the head of the epididymis. Schill
et al. (29) observed that infertile men suffering from oligozoospermia
and/or asthenozoospermia showed higher sperm concentrations after 3 mo
of captopril therapy. Also in this case, these results can be explained
with our model, in which ACE inhibitors increase
17
-estradiol production, permitting
a higher reabsorption of luminal fluid in the head epididymis.
Our data are not in agreement, however, with those reported by Hagaman et al. (13), in which mice lacking somatic and testicular ACE produced a normal number of sperm that were indistinguishable from wild-type sperm in assays of viability, motility, capacitation, and induction of acrosome reaction. These discrepancies require more investigation in view of the different experimental models.
In regards to prostaglandin production in frog testis, ANG II
influences PGF2
synthesis,
whereas PGE2 is not affected. In
newt brain, PGF2
influences
aromatase activity (11), whereas in frog testis there is no correlation
between PGF2
, stimulated by ANG
II, and aromatase activity. The influence on PGF2
production by ANG II
confirms what has been reported for frog ovary (4).
We conclude that ACE activity and ANG II independently influence aromatase activity, modulating estrogen production in a negative and positive way, respectively. The variations of estradiol concentration could influence the spermatogenesis in a feedback mechanism as reported in literature. Our results suggest a new physiological role for ACE and ANG II, still today considered mainly involved in regulation of blood pressure and hydromineral metabolism.
Perspectives
The study of the ACE-ANG II system in frog testis confirmed what was observed in frog ovary, in which ACE and ANG II independently regulate steroidogenesis and prostaglandin production. Moreover, in the case of frog testis, the two pathways seem to modulate aromatase activity and then estradiol production. In literature, estrogens have been reported to be involved in the inhibition of spermatogenesis and, furthermore, in humans an increase of estradiol level has been demonstrated in patients suffering from infertility. Our results, obtained in amphibian testis, if confirmed in mammals, may help to elucidate mechanisms for paracrine regulation of mammal testis steroidogenesis.| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by Ministero dell'Università e della Ricerca Scientifica e Tecnologica grants.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: Prof. D. Amici, Dipartimento di Biologia Molecolare, Cellulare e Animale, Università di Camerino, Via F. Camerini n. 2, I-62032 Camerino (MC), Italy (E-mail:amici{at}camserv.unicam.it).
Received 12 November 1998; accepted in final form 28 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bernstein, K. E.,
B. M. Martin,
E. A. Bernstein,
J. Linton,
L. Striker,
and
G. Striker.
The isolation of angiotensin converting enzyme cDNA.
J. Biol. Chem.
263:
11021-11024,
1988
2.
Bernstein, K. E.,
B. M. Martin,
A. S. Edwards,
and
E. A. Bernstein.
Mouse angiotensin-converting enzyme is a protein composed of two homologous domains.
J. Biol. Chem.
264:
11945-11951,
1989
3.
Bradford, M. A.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
4.
Bramucci, M.,
A. Miano,
A. Gobbetti,
M. Zerani,
L. Quassinti,
E. Maccari,
O. Murri,
and
D. Amici.
Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R2089-R2096,
1997
5.
Carani, C.,
K. Qin,
M. Simoni,
M. Faustini-Fustini,
S. Serpente,
J. Boyd,
K. S. Korach,
and
E. R. Simpson.
Effect of testosterone and estradiol in a man with aromatase deficiency.
N. Engl. J. Med.
337:
91-95,
1997
6.
Cushman, D. W.,
and
H. S. Cheung.
Concentrations of angiotensin-converting enzyme in tissues of the rat.
Biochim. Biophys. Acta
250:
261-265,
1971[Medline].
7.
Duncan, D. B.
Multiple range and multiple F test.
Biometrics
11:
1-42,
1955.
8.
Ehlers, M. R. W.,
E. A. Fox,
D. J. Strydom,
and
J. F. Riordan.
Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.
Proc. Natl. Acad. Sci. USA
86:
7741-7745,
1989
9.
Esther, C. R., Jr.,
T. E. Howard,
E. M. Marino,
J. M. Goddard,
M. R. Capecchi,
and
K. E. Bernstein.
Mice lacking angitensin-converting enzyme have low blood pressure, renalpathology, and reduced male fertility.
Lab. Invest.
74:
953-965,
1996[Medline].
10.
Gobbetti, A.,
and
M. Zerani.
Amphibian oocyte: a model of a possible regulatory mechanism for prostaglandin E2 and prostaglandin F2
synthesis.
J. Endocrinol.
145:
235-241,
1995
11.
Gobbetti, A.,
and
M. Zerani.
Prostaglandin E2 -9- ketoreductase and prostaglandin F2
activate brain aromatase to induce courtship in the male crested newt, Triturus carnifex.
Horm. Behav.
29:
267-277,
1995[Medline].
12.
Gorczynska, E.,
J. Spaliviero,
and
D. J. Handelsman.
Cyclic adenosine 3',5'-monophosphate-indipendent regulation of cytosolic calcium in Sertoli cells.
Endocrinology
137:
2617-2625,
1996[Abstract].
13.
Hagaman, J. R.,
J. S. Moyer,
E. S. Bachman,
M. Sibony,
P. L. Magyar,
J. E. Welch,
O. Smithies,
J. H. Krege,
and
D. A. O'Brien.
Angiotensin-converting enzyme and male fertility.
Proc. Natl. Acad. Sci. USA
95:
2552-2557,
1998
14.
Hara, A.,
K. Fukuyoma,
and
W. L. Epstein.
Angiotensin converting enzyme measured in mouse tissue by inhibition of histidyl-leucine peptidase.
Biochem. Med.
26:
199-210,
1981[Medline].
15.
Hess, R. A.,
D. Bunick,
K. Lee,
J. Bahr,
J. A. Taylor,
K. S. Korach,
and
D. B. Lubahn.
A role for oestrogens in the male reproductive system.
Nature
390:
509-512,
1997[Medline].
16.
Hooper, N. M.
Angiotensin converting enzyme: implications from molecular biology for its physiological functions.
Int. J. Biochem.
23:
641-647,
1991[Medline].
17.
Hooper, N. M.,
and
A. J. Turner.
Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: a re-evaluation of their role in neuropeptide metabolism.
Biochem. J.
241:
625-633,
1987[Medline].
18.
Howard, T. E.,
S. Y. Shai,
K. G. Langford,
B. M. Martin,
and
K. E. Bernstein.
Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene.
Mol. Cell. Biol.
10:
4294-4302,
1990
19.
Hubert, C.,
A. M. Houot,
P. Corvol,
and
F. Soubrier.
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicate gene.
J. Biol. Chem.
266:
15377-15383,
1991
20.
Khanum, A.,
and
M. L. Dufau.
Angiotensin II receptors and inhibitory actions in Leydig cells.
J. Biol. Chem.
263:
5070-5074,
1988
21.
Krege, J. H.,
S. W. M. John,
L. L. Langenbach,
J. B. Hodgin,
J. R. Hagaman,
E. S. Bachman,
J. C. Jennette,
D. A. O'Brien,
and
O. Smithies.
Male-female differences in fertility and blood pressure in ACE-deficient mice.
Nature
375:
146-148,
1995[Medline].
22.
Kumar, R. S.,
T. J. Thekkumkara,
and
G. C. Sen.
The mRNAs encoding the two angiotensin-converting isozymes are transcribed from same gene by a tissue-specific choice of alternative transcription initiation sites.
J. Biol. Chem.
266:
3854-3862,
1991
23.
Lattion, A. L.,
F. Soubrier,
J. Allegrini,
C. Hubert,
P. Corvol,
and
F. Alhenc-Gelas.
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme.
FEBS Lett.
252:
99-104,
1989[Medline].
24.
Lofts, B.
Seasonal changes in the functional activity of the interstitial and spermatogenetic tissues of the green frog, Rana esculenta.
Gen. Comp. Endocrinol.
4:
550-562,
1964.
25.
Millan, M. A.,
and
G. Aguilera.
Angiotensin II receptors in testes.
Endocrinology
122:
1984-1990,
1988[Abstract].
26.
Minucci, S.,
L. Dimatteo,
P. Chieffi,
R. Pierantoni,
and
S. Fasano.
17
-Estradiol effects on mast cell number and spermatogonial mitotic index in the testis of the frog, Rana esculenta.
J. Exp. Zool.
278:
93-100,
1997[Medline].
27.
Mukhopadhyay, A. K.,
J. Cobilanschi,
W. Schulze,
B. Brunswig-Spickenheier,
and
F. A. Leidenberger.
Human seminal fluid contains significant quantities of prorenin: its correlation with the sperm density.
Mol. Cell. Endocrinol.
109:
219-224,
1995[Medline].
28.
Rastogi, R. K.,
L. Iela,
P. K. Saxena,
and
G. Chieffi.
The control of spermatogenesis in the green frog, Rana esculenta.
J. Exp. Zool.
196:
151-166,
1976.
29.
Schill, W. B.,
E. M. Parsch,
and
W. Miska.
Inhibition of angiotensin-converting enzyme-a new concept of medical treatment of male infertility?
Fertil. Steril.
61:
1123-1128,
1994[Medline].
30.
Shetty, G.,
H. Krishnamurthy,
H. N. Krishnamurthy,
A. S. Bhatnagar,
and
N. R. Moudgal.
Effect of long-term treatment with aromatase inhibitor on testicular function of adult male bonnet monkeys (M. radiata).
Steroids
63:
414-420,
1998[Medline].
31.
Sibony, M.,
D. Segretain,
and
J. M. Gasc.
Angiotensin-converting enzyme in murine testis: step-specific expression of the germinal isoform during spermatogenesis.
Biol. Reprod.
50:
1015-1026,
1994[Abstract].
32.
Sokal, R. R.,
and
F. J. Rohlf.
Biometry (2nd ed.). San Francisco, CA: Freeman, 1981.
33.
Thekkumkara, T. J.,
W. Livingston,
R. S. Kumar,
and
G. C. Ser.
Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs.
Nucleic Acids Res.
20:
683-687,
1992
34.
Van Sande, M. E.,
S. L. Scharpé,
H. M. Neels,
and
K. O. Van Camp.
Distribution of angiotensin converting enzyme in human tissues.
Clin. Chim. Acta
147:
255-260,
1985[Medline].
35.
Varriale, B.,
R. Pierantoni,
L. Di Matteo,
S. Minucci,
S. Fasano,
M. D'Antonio,
and
G. Chieffi.
Plasma and testicular estradiol and plasma androgen profile in the male frog Rana esculenta during the annual cycle.
Gen. Comp. Endocrinol.
64:
401-404,
1986[Medline].
36.
Velletri, P. A.,
D. R. Aquilano,
E. Brukwick,
C. H. Tsai-Morris,
M. L. Dufau,
and
W. Lovenberg.
Endocrinological control and cellular localization of rat testicular angiotensin-converting enzyme (E. C. 3.4.15.1).
Endocrinology
116:
2516-2522,
1985[Abstract].
37.
Yamaguchi, T.,
S. Kurihara,
M. Ikekita,
K. Kiziki,
and
H. Moriya.
Angiotensin I converting enzyme activity in the kidney of bullfrog (Rana catesbeiana).
J. Pharmacobio-Dyn.
9:
585-592,
1986[Medline].
38.
Zerani, M.,
F. Amabili,
and
A. Gobbetti.
Plasma testosterone and 17
-estradiol concentrations, and aromatase activity, during courtship in male Triturus carnifex.
Horm. Behav.
26:
56-61,
1992[Medline].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |